51 results on '"Adams, Kirkwood F Jr"'
Search Results
2. Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week
3. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials
4. Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
5. Potential Roles of Vaptans in Heart Failure: Experience from Clinical Trials and Considerations for Optimizing Therapy in Target Patients
6. Genetic Tailoring of Pharmacotherapy in Heart Failure: Optimize the Old, While We Wait for Something New
7. Coping Effectively With Heart Failure (COPE-HF): Design and Rationale of a Telephone-Based Coping Skills Intervention
8. Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure
9. Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure
10. Prospective assessment of the occurrence of anemia in patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry
11. Hospitalizations Due to Unstable Angina Pectoris in Diastolic and Systolic Heart Failure
12. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction
13. Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients
14. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF)
15. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
16. Anemia as a risk factor and therapeutic target in heart failure
17. Risk stratification after hospitalization for decompensated heart failure
18. Gender differences in advanced heart failure: insights from the BEST study
19. Selective versus nonselective β-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
20. Guiding heart failure care by invasive hemodynamic measurements: Possible or useful?
21. Clinical benefits of low serum digoxin concentrations in heart failure
22. New epidemiologic perspectives concerning mild-to-moderate heart failure
23. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
24. 091 - Influence of Neurohormonal Antagonists on the Association of Loop Diuretic Dose with Mortality in Patients with Heart Failure: Insights From the UNITE-HF Registry
25. Investigating the Role of Thiazide-Like Diuretics in Acute Heart Failure: Potential Approach to an Unmet Need
26. Changes in Resting and Maximal Exercise Heart Rate during Dosing of Beta Blocker Therapy in Patients with Systolic Heart Failure
27. Relationship of Left Ventricular Size to Long-Term Outcome Varies with Degree of Clinical Heart Failure: Results from the UNC Heart Failure Database
28. Rationale and Design for the UNC Duke Acute Decompensated Heart Failure with Hypertension Study (UNDU ADHF-HTN)
29. Decreasing Hemoglobin during Follow-Up Is Associated with Declining Quality of Life in Unselected Outpatients with Heart Failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry
30. Diabetes Reduces the Likelihood of More Favorable Outcomes in Women Than Men with Heart Failure: Retrospective Analysis of the DIG Trial
31. Relationship of Clinical Signs and Chest-X Ray Congestion to the Efficacy of Digoxin in Patients with Chronic Heart Failure: A Retrospective Analysis of the Digoxin Investigation Group Trial
32. 842-6 Anemia is associated with reduced health status measures in patients with heart failure: Results from the STAMINA: HFP (study of anemia in a heart failure population) registry
33. 1069-119 Predictors of mortality in patients hospitalized with worsening heart failure: Insights from the ACTIV in CHF trial
34. 1012-126 Contemporary dosing of angiotensin converting enzyme inhibitors and beta blockers in chronic heart failure: Report from the STAMINA:HFP (study of anemia in a heart failure population) registry
35. A prospective randomized study of nesiritide versus dobutamine in decompensated heart failure (PRESERVD-HF): design and preliminary data
36. Results of a twelve week double-blind, placebo-controlled, multicenter study of oral conivaptan to assess functional capacity in patients with class III chronic heart failure
37. Risk of death in patients with preserved systolic function: retrospective analysis of the digitalis investigational group (DIG) trial
38. Reply
39. The impact of gender on prognosis in patients with advanced heart failure
40. Editorial comment
41. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy
42. Clinical definition and epidemiology of advanced heart failure
43. Safety and efficacy of epoprostenol in patients with severe congestive heart failure
44. Is there a role for epoprostenol in the management of heart failure?
45. Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failure
46. Capítulo 17 - Tratamiento de la insuficiencia cardíaca congestiva
47. Capítulo 12 - Miocardiopatía dilatada
48. Chapter 40 - Development and Implementation of Practice Guidelines in Heart Failure
49. Post hoc subgroup analysis and the truth of a clinical trial
50. Colaboradores
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.